SAFFRON GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: C82046 | LEICESTER, LE2 6UL
Showing results 51-100 of 781
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Empagliflozin | 1,617 | 50.8K | £63.1K | +158.4% ▲ |
| Ferrous fumarate | 1,530 | 91.5K | £3.2K | +111.1% ▲ |
| Tamsulosin hydrochloride | 1,522 | 51.5K | £2.1K | +12.3% ▲ |
| Buprenorphine | 1,483 | 9,541 | £28.4K | +304.8% ▲ |
| Allopurinol | 1,476 | 67.0K | £1.5K | +43.2% ▲ |
| Rosuvastatin calcium | 1,473 | 46.3K | £1.8K | +64.1% ▲ |
| Tiotropium bromide | 1,437 | 12.3K | £33.7K | +372.6% ▲ |
| Amoxicillin | 1,421 | 59.6K | £1.7K | +52.4% ▲ |
| Other emollient preparations | 1,408 | 758.7K | £10.5K | +134.4% ▲ |
| Spironolactone | 1,391 | 38.6K | £3.8K | +158.0% ▲ |
| 1,387 | 1,412 | £62.4K | +346.5% ▲ | |
| Gabapentin | 1,387 | 138.4K | £4.9K | +38.9% ▲ |
| Lamotrigine | 1,386 | 85.3K | £8.4K | +134.7% ▲ |
| Alginic acid compound preparations | 1,373 | 742.5K | £10.2K | +134.4% ▲ |
| 1,334 | 150.1K | £4.5K | +382.4% ▲ | |
| Alendronic acid | 1,328 | 5,768 | £1.6K | +77.0% ▲ |
| Isosorbide mononitrate | 1,293 | 45.3K | £6.1K | +95.6% ▲ |
| Estradiol | 1,293 | 96.4K | £16.0K | +57.6% ▲ |
| Gliclazide | 1,282 | 113.5K | £3.1K | +50.7% ▲ |
| Budesonide | 1,274 | 1,703 | £40.9K | +135.1% ▲ |
| 1,262 | 2,514 | £88.5K | +131.5% ▲ | |
| Senna | 1,259 | 67.1K | £1.5K | +109.2% ▲ |
| 1,256 | 19.0K | £11.0K | +89.1% ▲ | |
| Betamethasone valerate | 1,218 | 91.2K | £5.6K | +216.4% ▲ |
| Hydrocortisone | 1,180 | 38.5K | £6.9K | +163.2% ▲ |
| Doxycycline hyclate | 1,158 | 17.2K | £1.7K | +125.9% ▲ |
| Sodium valproate | 1,152 | 164.5K | £19.4K | +262.2% ▲ |
| 1,147 | 7,343 | £2.4K | +420.5% ▲ | |
| Bendroflumethiazide | 1,142 | 45.6K | £763 | +47.6% ▲ |
| Felodipine | 1,132 | 35.7K | £5.2K | +90.6% ▲ |
| Rivaroxaban | 1,126 | 21.0K | £14.5K | +84.0% ▲ |
| Montelukast | 1,121 | 33.3K | £1.6K | +63.7% ▲ |
| Insulin glargine | 1,121 | 6,665 | £55.2K | +294.8% ▲ |
| Edoxaban | 1,095 | 32.3K | £53.7K | +56.3% ▲ |
| Risperidone | 1,089 | 37.7K | £3.3K | +330.4% ▲ |
| Semaglutide | 1,060 | 29.9K | £85.1K | +340.2% ▲ |
| Influenza | 1,048 | 1,048 | £12.4K | -33.2% ▼ |
| Sildenafil (Erectile Dysfunction) | 1,013 | 5,170 | £730 | +101.0% ▲ |
| Sumatriptan succinate | 985 | 9,385 | £10.5K | +178.1% ▲ |
| Olanzapine | 981 | 29.1K | £3.3K | +164.8% ▲ |
| Mebeverine hydrochloride | 976 | 85.2K | £3.1K | +214.3% ▲ |
| Linagliptin | 956 | 28.2K | £31.8K | +133.4% ▲ |
| Lactulose | 942 | 588.7K | £5.5K | +186.1% ▲ |
| Melatonin | 942 | 69.9K | £14.7K | +183.3% ▲ |
| Flucloxacillin sodium | 938 | 53.1K | £3.0K | +108.6% ▲ |
| Levetiracetam | 925 | 149.6K | £11.6K | +102.1% ▲ |
| Meloxicam | 920 | 19.6K | £606 | +1,290.9% ▲ |
| Dihydrocodeine tartrate | 918 | 68.2K | £4.4K | +369.9% ▲ |
| 900 | 160.6K | £4.7K | +89.7% ▲ | |
| Insulin aspart | 890 | 5,394 | £33.0K | +133.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.